• News
  • Life
  • TV & Film
  • Beauty
  • Style
  • Home
  • News
    • Celebrity
    • Entertainment
    • Politics
    • Royal Family
  • Life
    • Animals
    • Food & Drink
    • Women's Health
    • Mental Health
    • Sex & Relationships
    • Travel
    • Real Life
  • TV & Film
    • True Crime
    • Documentaries
    • Netflix
    • BBC
    • ITV
    • Tyla Recommends
  • Beauty
    • Hair
    • Make-up
    • Skincare
  • Style
    • Home
    • Fashion
    • Shopping
  • Advertise
  • Terms
  • Privacy & Cookies
  • LADbible Group
  • LADbible
  • UNILAD
  • SPORTbible
  • GAMINGbible
  • UNILAD Tech
  • FOODbible
  • License Our Content
  • About Us & Contact
  • Jobs
  • Latest
  • Topics A-Z
  • Authors
Facebook
Instagram
X
Threads
TikTok
Submit Your Content
New study reveals unexpected health benefit from weight loss drugs that could help millions

Home> News

Published 18:28 22 Oct 2025 GMT+1

New study reveals unexpected health benefit from weight loss drugs that could help millions

A scientific study has revealed that GLP-1 drugs could be helping aid more than just weight loss

Madison Burgess

Madison Burgess

A new study has revealed an unexpected way that GLP-1 drugs could be aiding your health - and it's nothing to do with weight loss.

Drugs like Mounjaro and Wegovy have been increasing in popularity in the last few years. According to the BBC, an estimated 1.5 million people in the UK have turned to the jabs; meanwhile, across the pond, it was reported last year that a whopping one in eight adults in the US have tried a GLP-1 drug.

But, despite their popularity, users have been speaking out about a slew of different side effects, including hair loss, sickness, and heartburn, with buzzwords like 'Ozempic vulva' and 'Ozempic mouth' also popping up.

To be clear, Ozempic is not a weight loss drug and is only approved for the treatment of type 2 diabetes.

Advert

But now, a scientific study has revealed the surprising way that weight loss and type 2 diabetes drugs could be helping you out.

Weight loss drugs and type 2 diabetes medications could be aiding your health in more ways that one (Getty Stock Image)
Weight loss drugs and type 2 diabetes medications could be aiding your health in more ways that one (Getty Stock Image)

Research suggested that the drugs could actually reduce the risk of heart patients being hospitalised or dying early by half.

They have been found to offer 'dramatic benefits' to heart patients, significantly cutting their risk of becoming seriously ill, reports The Guardian.

Advert

The shock findings were presented at the 2025 European Society of Cardiology Congress in Madrid, Spain, last month.

How did the study work?

Researchers conducted trials involving patients with a type of heart failure called heart failure with preserved ejection fraction (HFpEF), and treated them with either GLP-1 receptor agonists or a placebo.

A total of 54 worsening heart failure events were reported among 1,914 patients receiving GLP1-receptor antagonist treatment, compared to 86 events among 1,829 patients receiving placebo.

Advert

In short, it revealed that tirzepatide cut the risk of hospitalisation for heart failure or death from any cause by 58 percent, while those taking semaglutide were 42 percent less likely.

Author of the groundbreaking study, which was the largest of its kind, Dr Nils Krüger, said: “Despite the widespread morbidity and mortality burden of HFpEF, current treatment options are limited.

The drugs had 'dramatic benefits' for heart patients (Getty Stock Image)
The drugs had 'dramatic benefits' for heart patients (Getty Stock Image)

"Both semaglutide and tirzepatide are well known for their effects on weight loss and blood sugar control, but our study suggests they may also offer substantial benefits to patients with obesity and type 2 diabetes by reducing adverse heart failure outcomes."

Advert

She added: “Our findings show that in the future, GLP-1 targeting medications could provide a much-needed treatment option for patients with heart failure.”

Meanwhile, Dr Carlos Aguiar, the vice-president of the European Society of Cardiology and a renowned expert in heart failure, has praised the findings.

He said: “What this shows is that there is a benefit in using one of these two agents, semaglutide or tirzepatide, to reduce the risk of hospitalisation for heart failure or all-cause mortality.

“We thought that we actually might not really find a treatment that would work well for a significant proportion of these patients, and what’s been a good surprise is that these drugs that are working through weight loss, but possibly through other effects that go beyond weight loss, are potentially reducing the rates of hospitalisation and mortality in patients with heart failure."

Featured Image Credit: Getty Stock Image

Topics: Mounjaro, Ozempic, News, Health, World News, Science

Madison Burgess
Madison Burgess

Madison is a Journalist at Tyla with a keen interest in lifestyle, entertainment and culture. She graduated from the University of Sheffield with a first-class degree in Journalism Studies, and has previously written for DMG Media as a Showbiz Reporter and Audience Writer.

Advert

Advert

Advert

  • Weight loss drugs side effects explained as doctors issue fresh warning over ‘unusual’ complication
  • Hollywood plastic surgeon reveals alarming side-effect weight loss drugs can have ‘down there’
  • Weight loss jab ‘golden dose’ explained as doctor issues warning to users trying it
  • Elon Musk reveals what he’s used to help new weight loss transformation

Choose your content:

5 mins ago
27 mins ago
an hour ago
  • Anna Moneymaker/Getty Images
    5 mins ago

    Donald Trump thanks 'Darth Vader' at recent conference and the audience's 'awkward' reaction says it all

    No, Trump wasn't talking about the actual fictional villain, but one of his White House staff members

    News
  • Yuri Gripas/Abaca/Bloomberg via Getty Images
    27 mins ago

    Donald Trump slammed for 'mansplaining' to female journalist in heated moment

    The Republican leader has divided opinion with how he answered a question about Ukraine and Russia on Monday (20 October)

    News
  • Kevin Dietsch/Getty Images
    an hour ago

    White House issues blunt statement over Trump 'considering pardoning Diddy's prison sentence'

    The White House has firmly shut down the speculation and blasted TMZ's claims as 'fake news'

    News
  • ALASTAIR GRANT/POOL/AFP via Getty Images
    an hour ago

    King Charles may have missed out on a 'unprecedented' honour from Pope Leo after breaking major tradition

    The King will travel to the Vatican to visit the Pope

    News